Glucose metabolism in patients with psoriasis.
CONCLUSIONS: The available literature does not unequivocally support common pathophysiological denominators in psoriasis and T2D. Well-designed clinical studies are needed to expose potential diabetogenic defects in the glucose metabolism in patients with psoriasis. This article is protected by copyright. All rights reserved.
PMID: 30376181 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Friis NU, Hoffmann N, Gyldenløve M, Skov L, Vilsbøll T, Knop FK, Storgaard H Tags: Br J Dermatol Source Type: research
More News: Databases & Libraries | Dermatology | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Insulin | Psoriasis | Skin | Study | UK Health